| Q90678511 | 5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA |
| Q36636744 | 5-HT1A partial agonists. What is their future? |
| Q24671763 | Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand |
| Q68094198 | Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test |
| Q74503944 | Antifungal effects of new heterocyclic compounds, 6H-pyrimido[2,1-a]isoindole derivatives |
| Q46647477 | Effects of selective 5-HT1A agonist tandospirone on the rate and rhythmicity of binocular rivalry |
| Q37932295 | Formation of active metabolites of psychotropic drugs. An updated review of their significance |
| Q28362123 | Gynecomastia induced by treatment with tandospirone, a 5-HT1A agonist |
| Q46695391 | Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes |
| Q80153668 | Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes |
| Q44728576 | Inhibition by 8-hydroxy-2-(di-n-propylamino) tetralin and SM-3997, a novel anxiolytic drug, of the hippocampal rhythmical slow activity mediated by 5-hydroxytryptamine1A receptors |
| Q48882243 | Pharmacological profile of a potential anxiolytic: AP159, a new benzothieno-pyridine derivative |
| Q45228126 | Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo |
| Q42132920 | The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist |
| Q26795511 | The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory |